Cargando…

A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects

The adoptive transfer of anti-CD19 chimeric antigen receptor (CAR)-engineered T cells has shown impressive clinical responses in patients with refractory B-cell malignancies(1–7). However, the therapeutic effects of CAR-T cells targeting other malignancies have not yet resulted in significant clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kagoya, Yuki, Tanaka, Shinya, Guo, Tingxi, Anczurowski, Mark, Wang, Chung-Hsi, Saso, Kayoko, Butler, Marcus O., Minden, Mark D., Hirano, Naoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839992/ https://www.ncbi.nlm.nih.gov/pubmed/29400710 http://dx.doi.org/10.1038/nm.4478

Ejemplares similares

DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
por: Kagoya, Yuki, et al.
Publicado: (2018)

Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP(84Gly)
por: Anczurowski, Mark, et al.
Publicado: (2018)

HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway
por: Yamashita, Yuki, et al.
Publicado: (2017)

CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells
por: Nakatsugawa, Munehide, et al.
Publicado: (2016)

Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors
por: Guo, Tingxi, et al.
Publicado: (2016)

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma
por: Murata, Kenji, et al.
Publicado: (2020)

Epigenetic engineering for optimal chimeric antigen receptor T cell therapy
por: Ito, Yusuke, et al.
Publicado: (2022)

Gastrokine 2 Regulates the Antitumor Effect of JAK2/STAT3 Pathway in Gastric Cancer
por: Zhou, Yu, et al.
Publicado: (2021)

Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
por: Xiong, Xinxin, et al.
Publicado: (2022)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Adoptive T Cell Therapy Targeting CD1 and MR1
por: Guo, Tingxi, et al.
Publicado: (2015)

The Antitumor and Immunomodulatory Effect of Yanghe Decoction in Breast Cancer Is Related to the Modulation of the JAK/STAT Signaling Pathway
por: Mao, Dan, et al.
Publicado: (2018)

A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling
por: Wang, Dong-Ping, et al.
Publicado: (2023)

Retracted: Gastrokine 2 Regulates the Antitumor Effect of JAK2/STAT3 Pathway in Gastric Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

JAK/STAT Signalling in Huntington’s Disease Immune Cells
por: Träger, Ulrike, et al.
Publicado: (2013)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects
por: Zhou, Jianxia, et al.
Publicado: (2019)

Distinct Patterns of DNA Damage Response and Apoptosis Correlate with Jak/Stat and PI3Kinase Response Profiles in Human Acute Myelogenous Leukemia
por: Rosen, David B., et al.
Publicado: (2010)

Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma
por: Tomida, Akimasa, et al.
Publicado: (2021)

Role of JAK-STAT signaling in maturation of phagosomes containing Staphylococcus aureus
por: Zhu, Fei, et al.
Publicado: (2015)

JAK-STAT in heterochromatin and genome stability
por: Silver-Morse, Louise, et al.
Publicado: (2013)

JAK-STAT and intestinal mucosal immunology
por: Heneghan, Aaron F, et al.
Publicado: (2013)

JAK-STAT: Getting to the heart of the matter
por: Barry, Sean P.
Publicado: (2012)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

JAK-STAT in Early Hematopoiesis and Leukemia
por: Fasouli, Eirini Sofia, et al.
Publicado: (2021)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
por: Govaerts, Inge, et al.
Publicado: (2019)

Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
por: Furqan, Muhammad, et al.
Publicado: (2013)

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)

Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris
por: Juczynska, K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4c16ikdu21b2h9rsflia4841f2